期刊文献+

乙醇阻滞胫神经运动支治疗脑卒中足下垂 被引量:9

Effects of alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle on foot drop in patients with stroke
下载PDF
导出
摘要 目的观察胫神经运动支乙醇阻滞腓肠肌治疗老年脑卒中偏瘫后足下垂的临床结果。方法22例腓肠肌痉挛导致足下垂脑卒中偏瘫老年患者在电刺激引导定位下接受胫神经运动支无水酒精阻滞。采用踝跖屈改良Ashworth分级、踝阵挛分级以及被动踝关节活动度分别在注射前、注射后即刻、1 d、1周、1月以及3月进行肌痉挛严重程度评估。结果19例患者在3月随访期中改良Ashworth分级均明显下降,3例1周后进行重复注射。与注射前比较,注射后Ashworth分级(MAS)、踝阵挛分级(Clonus)、被动踝关节活动度(PROM)有显著性差异(P<0.01)。3月期间未发现严重的不良反应。结论胫神经运动支乙醇阻滞腓肠肌治疗脑卒中后偏瘫足下垂安全有效。 Objective To observe the clinical effects of alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle on foot drop in patients with hemiplegic stroke. Methods Twenty-two patients with hemiplegie stroke showing foot drop due to gastrocnemius ankle plantarflexor spasticity accepted motor branch block (MBB) of the tibial nerve to the gastrocnemius muscle with 99. 9% ethyl alcohol. The severity of spasticity was assessed before and after MBB (0 h, 24 h,7 days, 1 month and 3 months) , using the Modified Ashworth Scale (MAS) score of ankle plantarflexor, clonus score of the ankle, and the passive range of motion (PROM) of ankle dorsiflexion. The Friedman test was used to compare the mean values before and after MBB. Results The MAS score was reduced in 19 patients during the 3-month follow- up, and spasticity reappeared at the level of the pre-MBB state in 3 patients who received repeated motor block. No serious complications were observed during the 3-month follow-up period. Conclusions MBB of the tibial nerve to the gastrocnemius muscle is effective and safe for relieving localized muscle spasticity of the ankle plantarflexors in patients with hemiplegic stroke.
出处 《实用老年医学》 CAS 2008年第6期447-448,480,共3页 Practical Geriatrics
关键词 脑卒中 乙醇阻滞 胫神经运动支 肌痉挛 stroke alcohol neurolysis tibial nerve motor branches muscle spasticity
  • 相关文献

参考文献11

二级参考文献22

  • 1刘建军,胡莹媛,李燕春,吴卫红,陆华宝,张雁.酚阻滞术治疗痉挛型脑瘫的疗效分析[J].现代康复,1999,3(12):1418-1419. 被引量:5
  • 2Das TK, Park DM.Effect of treatment with botulinum toxin on spasticity[J].Postgrad Med J, 1989, 65:208. 被引量:1
  • 3Wallen MA, O'flahertv SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase Ⅱ trial [J]. Arch Phys Med Rehabil, 2004, 85(2):192. 被引量:1
  • 4Chua KS, Kong KH, Lui YC, et al. Botulinum toxin A in the treatment of hemiplegic spastic foot drop-clinical and functional outcomes[J]. Singapore Med J, 2000, 41(5):209. 被引量:1
  • 5Childers MK, Brashear A, Jozefczyk P, et al.Dose-dependent response to intramuscular botulinum toxin type A for upperlimb spasticity in patients after a strok [J].Arch Phys Med Rehabil, 2004, 85(7):1063. 被引量:1
  • 6Bakheit AM, Thihnann AF, Ward AB, et al. A randomized,double blind, placebo controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke[J]. Stroke, 2000, 31(10):2402. 被引量:1
  • 7Leonard CT, Stephens JU, Strople SL. Assessing the spastic condition of individuals with upper motoneuron involvement:Validity of the myotonometer[J]. Arch Phys Med Rehabil, 2001,82 (10):1416. 被引量:1
  • 8Dolly O. Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins [J]. Headache, 2003, 43(1):16. 被引量:1
  • 9Shaari CM, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis [J]. Muscle Nerve, 1993, 16(9):964. 被引量:1
  • 10Dressier D. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy [J]. Mov Disord, 2004, 19(8):S92. 被引量:1

共引文献39

同被引文献105

引证文献9

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部